| Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells A Facciabene, X Peng, IS Hagemann, K Balint, A Barchetti, LP Wang, ... Nature 475 (7355), 226-230, 2011 | 1154 | 2011 |
| Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors GT Motz, SP Santoro, LP Wang, T Garrabrant, RR Lastra, IS Hagemann, ... Nature medicine 20 (6), 607-615, 2014 | 754 | 2014 |
| Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis WT Hwang, SF Adams, E Tahirovic, IS Hagemann, G Coukos Gynecologic oncology 124 (2), 192-198, 2012 | 592 | 2012 |
| Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor E Lanitis, M Poussin, IS Hagemann, G Coukos, R Sandaltzopoulos, ... Molecular Therapy 20 (3), 633-643, 2012 | 204 | 2012 |
| Clinical next‐generation sequencing in patients with non–small cell lung cancer IS Hagemann, S Devarakonda, CM Lockwood, DH Spencer, K Guebert, ... Cancer 121 (4), 631-639, 2015 | 203 | 2015 |
| Validation of a next-generation sequencing assay for clinical molecular oncology CE Cottrell, H Al-Kateb, AJ Bredemeyer, EJ Duncavage, DH Spencer, ... The Journal of molecular diagnostics 16 (1), 89-105, 2014 | 181 | 2014 |
| High-throughput detection of prostate cancer in histological sections using probabilistic pairwise Markov models JP Monaco, JE Tomaszewski, MD Feldman, I Hagemann, M Moradi, ... Medical image analysis 14 (4), 617-629, 2010 | 156 | 2010 |
| Geometric Magnetic Frustration in Ba2Sn2Ga3ZnCr7O22: A Two-Dimensional Spinel Based Kagomé Lattice IS Hagemann, Q Huang, XPA Gao, AP Ramirez, RJ Cava Physical review letters 86 (5), 894-897, 2001 | 153 | 2001 |
| Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II TrialPembrolizumab in … R Uppaluri, KM Campbell, AM Egloff, P Zolkind, ZL Skidmore, ... Clinical Cancer Research 26 (19), 5140-5152, 2020 | 142 | 2020 |
| Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC). R Uppaluri, P Zolkind, T Lin, B Nussenbaum, RS Jackson, J Rich, ... Journal of Clinical Oncology 35 (15_suppl), 6012-6012, 2017 | 82 | 2017 |
| Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels E Lanitis, D Dangaj, IS Hagemann, DG Song, A Best, R Sandaltzopoulos, ... Plos one 7 (11), e49829, 2012 | 82 | 2012 |
| Risk of occult malignancy in morcellated hysterectomy: a case series IS Hagemann, AR Hagemann, VA LiVolsi, KT Montone, CS Chu International journal of gynecological pathology 30 (5), 476-483, 2011 | 74 | 2011 |
| T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides KE Sufficool, CM Lockwood, HJ Abel, IS Hagemann, JA Schumacher, ... Journal of the American Academy of Dermatology 73 (2), 228-236. e2, 2015 | 72 | 2015 |
| Synthesis, structure and physical properties of Ru ferrites: BaMRu5O11 (M= Li and Cu) and BaM′2Ru4O11 (M′= Mn, Fe and Co) ML Foo, Q Huang, JW Lynn, WL Lee, T Klimczuk, IS Hagemann, NP Ong, ... Journal of Solid State Chemistry 179 (2), 563-572, 2006 | 70 | 2006 |
| A phase II trial of neoadjuvant MK-2206, an AKT inhibitor, with anastrozole in clinical stage II or III PIK3CA-mutant ER-positive and HER2-negative breast cancerneoadjuvant MK … CX Ma, V Suman, MP Goetz, D Northfelt, ME Burkard, F Ademuyiwa, ... Clinical Cancer Research 23 (22), 6823-6832, 2017 | 67 | 2017 |
| Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor ImmunityBreast Cancer Neoantigens Can Induce Antitumor Immunity X Zhang, S Kim, J Hundal, JM Herndon, S Li, AA Petti, SD Soysal, L Li, ... Cancer immunology research 5 (7), 516-523, 2017 | 64 | 2017 |
| Evaluation of ovarian cancer: initial application of coregistered photoacoustic tomography and US S Nandy, A Mostafa, IS Hagemann, MA Powell, E Amidi, K Robinson, ... Radiology 289 (3), 740-747, 2018 | 62 | 2018 |
| Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers B Zhang, XY Xing, J Li, RF Lowdon, Y Zhou, N Lin, B Zhang, V Sundaram, ... BMC genomics 15, 1-21, 2014 | 59 | 2014 |
| The ovarian cancer chemokine landscape is conducive to homing of vaccine-primed and CD3/CD28–costimulated T cells prepared for adoptive therapy E Zsiros, P Duttagupta, D Dangaj, H Li, R Frank, T Garrabrant, ... Clinical Cancer Research 21 (12), 2840-2850, 2015 | 57 | 2015 |
| Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy IS Hagemann, CE Cottrell, CM Lockwood Cancer genetics 206 (12), 420-431, 2013 | 55 | 2013 |
George CoukosUniversity Hospital of Lausanne, Ludwig Institute for Cancer ResearchVerified email at chuv.ch
